Who has invested in Brickell Biotech?

Paul Kang, Palisade Capital Management are named among the investors backing Brickell Biotech.

Brickell Biotech Funding: $17M Raised, Series C (2015)

Brickell Biotech funding overview

Brickell Biotech is based in Miami. Brickell Biotech has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in February 2015. The round record for Brickell Biotech runs through 2015; nothing later has been disclosed. Investors on record include Paul Kang, Palisade Capital Management. 2 distinct backers are named across the disclosed rounds.

Brickell Biotech at a glance

Total raised: $17M
Latest round: Series C
Latest round date: February 2015
Headquarters: Miami
Notable investors: Paul Kang, Palisade Capital Management

Frequently asked about Brickell Biotech funding

How much has Brickell Biotech raised?: Brickell Biotech has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Brickell Biotech?: Paul Kang, Palisade Capital Management are named among the investors backing Brickell Biotech.
What was the latest Brickell Biotech funding round?: The most recent disclosed round is a Series C, announced in February 2015.
Where is Brickell Biotech based?: Brickell Biotech is based in Miami.
When did Brickell Biotech last raise?: The last disclosed Brickell Biotech round closed in February 2015 at Series C.

Brickell Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Miami below to benchmark round size and investor mix.

Brickell Biotech Funding: $17M Raised, Series C (2015)

Brickell Biotech funding overview

Brickell Biotech at a glance

Frequently asked about Brickell Biotech funding

Companies related to Brickell Biotech (18)

Browse related funding lists (3)